Galmed Pharmaceuticals Ltd (GLMD)
0.3925
-0.01
(-1.88%)
USD |
NASDAQ |
Apr 25, 16:00
0.3939
0.00 (0.00%)
Pre-Market: 09:02
Galmed Pharmaceuticals Cash from Operations (TTM): -6.137M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -6.137M |
September 30, 2023 | -9.263M |
June 30, 2023 | -10.20M |
March 31, 2023 | -14.74M |
December 31, 2022 | -18.50M |
September 30, 2022 | -21.47M |
June 30, 2022 | -27.34M |
March 31, 2022 | -29.06M |
December 31, 2021 | -32.89M |
September 30, 2021 | -33.74M |
June 30, 2021 | -30.36M |
March 31, 2021 | -28.98M |
December 31, 2020 | -26.29M |
September 30, 2020 | -22.52M |
June 30, 2020 | -20.78M |
March 31, 2020 | -17.70M |
December 31, 2019 | -14.94M |
September 30, 2019 | -13.12M |
June 30, 2019 | -11.11M |
March 31, 2019 | -9.379M |
December 31, 2018 | -9.023M |
Date | Value |
---|---|
September 30, 2018 | -9.257M |
June 30, 2018 | -10.29M |
March 31, 2018 | -11.66M |
December 31, 2017 | -12.07M |
September 30, 2017 | -12.41M |
June 30, 2017 | -12.72M |
March 31, 2017 | -12.92M |
December 31, 2016 | -12.13M |
September 30, 2016 | -11.53M |
June 30, 2016 | -10.58M |
March 31, 2016 | -9.298M |
December 31, 2015 | -8.474M |
September 30, 2015 | -8.856M |
June 30, 2015 | -8.646M |
March 31, 2015 | -9.28M |
December 31, 2014 | -9.241M |
September 30, 2014 | -7.54M |
June 30, 2014 | -6.486M |
March 31, 2014 | -4.29M |
December 31, 2013 | -2.524M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-33.74M
Minimum
Sep 2021
-6.137M
Maximum
Dec 2023
-20.48M
Average
-20.78M
Median
Jun 2020
Cash from Operations (TTM) Benchmarks
Compugen Ltd | -- |
Pluri Inc | -18.47M |
BioLine Rx Ltd | -22.61M |
Can Fite Biofarma Ltd | -- |
BiomX Inc | -21.29M |